The MFI 5000 platform is the next generation of Brightwell's MFI instruments that are used by pharmaceutical companies for analysing sub-visible particles in bio-therapeutics.
The MFI 5000 platform includes additional automation to further streamline the setup process and is packaged in an integrated format that reduces the benchtop footprint.
Most importantly, the MFI 5000 may be seamlessly integrated with the existing 4000 series of instruments.
This provides customers with equivalent performance using either platform, which is said to be crucial for continuity in formulation development and quality-control programme.
